Allucent
Silver Sponsor
Allucent, formed from the recent merger of CATO SMS and Pharm-Olam, is a global clinical services organization uniquely positioned to serve small and mid-sized biotech companies. With more than 30 years of experience in over 60 countries, we have supported over 200 rare and orphan disease clinical studies across a variety of novel therapy classes and precision medicine including; gene therapies, GMO’s, stem cell therapies, and mRNA and antisense therapies. With an integrated approach encompassing regulatory, clinical, and scientific expertise, we’re adept at overcoming the challenges of delivering novel treatments to patients.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events